Lancet Study That Caused WHO To Drop Hydroxychloroquine Trials Falls Under Scrutiny

Lancet Study Questioned

“An Australian study that has been 'touted' around the world as "proving" HCQ is unsafe against COVID-19 is now being questioned openly...

Questions have been raised by Australian infectious disease researchers about a study published in the Lancet which prompted the World Health Organization to halt global trials of the drug hydroxychloroquine to treat Covid-19.

Specifically, the study, led by the Brigham and Women’s Hospital Center for Advanced Heart Disease in Boston, examined patients in hospitals around the world, including in Australia. It said researchers gained access to data from five hospitals recording 600 Australian Covid-19 patients and 73 Australian deaths as of 21 April.

But data from Johns Hopkins University shows only 67 deaths from Covid-19 had been recorded in Australia by 21 April. The number did not rise to 73 until 23 April. The data relied upon by researchers to draw their conclusions in the Lancet is not readily available in Australian clinical databases, leading many to ask where it came from.”

“If they got this wrong, what else could be wrong?” Dr Allen Cheng, an epidemiologist and infectious disease doctor with Alfred Health in Melbourne, said. It was also a “red flag” to him that the paper listed only 4 authors.”

Read Our Latest News

Be the first to comment

Please check your e-mail for a link to activate your account.

This is an independent expenditure prepared and paid for by RIGHT NOW MINNESOTA, 8014 Olson Memorial HWY 55 #543 Golden Valley, MN 55427. It is not coordinated with or approved by any candidate nor is any candidate responsible for it.